GlassScriptPrepare for your visit
Cheryl K Brophy
Family · Grand Blanc, MI · NPI 1760898399
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$2,159.47
in general payments reported to CMS, 2019-2025 · $365 in 2025
The $365 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $557.84
- Sumitomo Pharma America, INC. $238.28
- Myovant Sciences INC. $215.81
- Organon LLC $197.89
- Aspira Women'S Health INC $183.94
- Mayne Pharma Commercial LLC $149.69
Drugs and devices associated with these payments
Myfembree Liletta Nexplanon Ova1 Ozempic Aptima Thinprep 2000 Processor Reltone 400 Mg Glycate Reltone 200 Mg Veozah Pico 7
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Cheryl Brophy listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10502997/cheryl-k-brophy